Platinum-Resistant Urothelial Carcinoma
3 clinical trials · Condition
◉ Watch Platinum-Resistant Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372) | xCures | 2021-11-21 |
| NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma (NCT04851834) | Xennials Therapeutics Australia Pty Ltd | 2021-08-25 |
Track Platinum-Resistant Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.